Carlos Vallejo
Overview
Explore the profile of Carlos Vallejo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scheinberg P, Finelli C, Montano-Figueroa E, Vallejo C, Norasetthada L, Calado R, et al.
Lancet Haematol
. 2024 Feb;
11(3):e206-e215.
PMID: 38335978
Background: Antithymocyte globulin (ATG)-based immunosuppression is standard in front-line treatment for people with severe aplastic anaemia without a histocompatible donor or who are 40 years or older. However, ATG requires...
2.
Vallejo C, Rosell A, Xicoy B, Garcia C, Albo C, Polo M, et al.
Ann Hematol
. 2024 Jan;
103(3):705-713.
PMID: 38175253
Aplastic anemia (AA) is a rare, life-threatening hematological disease, with a poorly defined incidence. As the data available on AA varies substantially worldwide, a multicenter, ambispective, observational study was carried...
3.
Vallejo C, Jarque I, Fortun J, Casado A, Peman J
J Fungi (Basel)
. 2023 Jun;
9(6).
PMID: 37367564
Recent advances in the treatment of hematologic malignancies have improved the overall survival rate, but the number of patients at risk of developing an invasive fungal infection (IFI) has increased....
4.
Hernandez-Boluda J, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, et al.
Bone Marrow Transplant
. 2022 Apr;
57(6):1051.
PMID: 35361897
No abstract available.
5.
Hernandez-Boluda J, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, et al.
Bone Marrow Transplant
. 2022 Jan;
57(3):416-422.
PMID: 35066569
Allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for patients with myeloid/lymphoid neoplasm (MLN) with FGFR1 rearrangement, but data on overall results are limited. We report on the...
6.
Bueno F, Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, et al.
Transpl Infect Dis
. 2021 Apr;
23(4):e13627.
PMID: 33908148
The potential role of active CMV infection in promoting acute Graft-versus-Host Disease (aGvHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a matter of debate. We further addressed this issue...
7.
Giammarco S, Sica S, Chiusolo P, Laurenti L, Sora F, Martino M, et al.
Int J Hematol
. 2021 Apr;
114(2):228-234.
PMID: 33886103
This retrospective study assessed the effectiveness of eltrombopag (EPAG), a thrombopoietin receptor agonist, in the treatment of poor graft function (PGF) following an allogeneic haemopoietic stem cell transplantation (HSCT). Complete...
8.
Gonzalez Vicent M, Diaz de Heredia C, Gonzalez de Pablo J, Molina B, Regueiro A, Perez Martinez A, et al.
Eur J Haematol
. 2021 Mar;
106(6):842-850.
PMID: 33713387
Background: Defibrotide is approved in European Union for the treatment of severe sinusoidal obstruction syndrome (SOS) after HSCT. However, it has also been used for SOS prophylaxis, moderate SOS and...
9.
Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, et al.
Bone Marrow Transplant
. 2020 Dec;
56(6):1281-1290.
PMID: 33319853
There is limited information on the impact of CMV DNAemia episodes developing prior to engraftment (pre-CMV DNAemia) on clinical outcomes following allogeneic hematopoietic stem cell transplantation (allo-HSCT). This issue was...
10.
Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, et al.
Am J Transplant
. 2020 Aug;
21(1):258-271.
PMID: 32812351
The net impact of cytomegalovirus (CMV) DNAemia on overall mortality (OM) and nonrelapse mortality (NRM) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a matter of debate. This was a...